[SaneVax: Attempts to manufacture fear of cervical cancer was not enough to convince more than 20% of eligible adolescent girls in the U.S. to submit to HPV vaccines. According to a new ‘study’ perhaps fear of contracting an STD will change that. The SaneVax team issues a warning to medical consumers: Do not be fooled by new […]
Archives for May 2013
The Potential Significance of Aluminum/DNA Compounds in Gardasil on Health
By Norma Erickson Each dose of Gardasil contains 225mcg of aluminum-based adjuvant. Adjuvants are in vaccines to bring the antigen (the substance that stimulates the specific protective immune response) into contact with the immune system and influence the type of immunity produced, as well as the magnitude or duration of the immune response. In the […]
SaneVax Announces a New Gardasil Cervarix HPV Vaccine Survey
The SaneVax team is pleased to announce an opportunity for Gardasil and Cervarix HPV vaccine recipients and their families to help provide data regarding HPV vaccines’ risk versus benefit profile. The study is being conducted by an independent scientist, Dr. Chandler Marrs, and hosted on her website, Hormones Matter TM. The purpose of this study […]
Debate: Routine meningitis vaccines for infants?
[SaneVax: Health authorities in the United States are currently debating whether to administer a new meningococcol vaccine to those infants at high risk for the disease, or add it to the routine immunization schedule and give it to all infants, whether they are likely to contract the disease or not. Listen to both sides of the […]
SaneVax response to journal article promoting proposed nine-valent HPV vaccine
[Sanevax: The following letter to the editors of Infectious Agents and Cancer was submitted as a response to “Potential impact of a nine-valent vaccine in human papillomavirus related cancers,” by Sylvia de Sanjosé, et al. After peer-review and approval, the letter was published in this month’s edition of Infectious Agents and Cancer.] Dear Editors In Chief: The article entitled […]